Skip to main content
Professor Peter Goadsby
Image of Professor Peter Goadsby

Professor Peter Goadsby MBBS MD PhD DSc FRACP FRCP

Director of NIHR Clinical Research Facility & Professor of Neurology

Research interests

  • Neuroscience

Biography

My major research interests are in the basic mechanisms of primary headache disorders, such as migraine and cluster headache, in both experimental and clinical settings, and translating these insights into their better management.

I am the Director of the National Institute for Health Research - Wellcome Trust King’s Clinical Research Facility (CRF). The CRF provides dedicated facilities to support the delivery of externally-funded early translational, experimental medical research, including early-phase studies and early translational research studies that are nested within later-phase studies.

I lead the Biomedical Research Council Themes; Clinical Research Facility, and Pain and Headache. I am also the National Lead for Neurological Disorders for the Clinical Research Network, NIHR UK, a Trustee of the Organisation for the Understanding of Cluster Headache (OUCH UK) and Chair of the Scientific Programme Committee, Migraine Trust International Symposium. I also lead the Pain and Addictions theme at the NIHR Maudsley Biomedical Research Centre.

Please see my Research Staff Profile for more detail.

Key collaborators:

  • Dr Philip Holland, King's College London
  • Dr Jan Hoffmann, King's College London
  • Professor Steve Williams, King's College London
  • Dr Fernando Zelaya, King's College London

News

Professor Peter Goadsby elected to the Fellowship of the Royal Society

Professor Peter Goadsby from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) has been elected to the Fellowship of the Royal Society, a...

Professor Peter Goadsby

Two IoPPN researchers become Fellows of the Royal Society

Professors Peter Goadsby and Oscar Marín, both of the Institute of Psychiatry, Psychology & Neuroscience’s (IoPPN) School of Neuroscience, have been elected...

blue brain outline

New collaboration with digital therapeutics company to investigate preventable opioid respiratory deaths

A new collaboration between the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London and the digital therapeutics company,...

drug dose

Professor Peter Goadsby awarded world's top Brain Prize 2021

Peter Goadsby, Professor of Neurology at King's College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN), and Director at the National...

Professor Peter Goadsby

Spotlight

Tackling migraine head on

Until recently there has been little hope for effective treatment for migraine, meaning that more than one billion people around the world who experience this...

new migraine drug

News

Professor Peter Goadsby elected to the Fellowship of the Royal Society

Professor Peter Goadsby from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) has been elected to the Fellowship of the Royal Society, a...

Professor Peter Goadsby

Two IoPPN researchers become Fellows of the Royal Society

Professors Peter Goadsby and Oscar Marín, both of the Institute of Psychiatry, Psychology & Neuroscience’s (IoPPN) School of Neuroscience, have been elected...

blue brain outline

New collaboration with digital therapeutics company to investigate preventable opioid respiratory deaths

A new collaboration between the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London and the digital therapeutics company,...

drug dose

Professor Peter Goadsby awarded world's top Brain Prize 2021

Peter Goadsby, Professor of Neurology at King's College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN), and Director at the National...

Professor Peter Goadsby

Spotlight

Tackling migraine head on

Until recently there has been little hope for effective treatment for migraine, meaning that more than one billion people around the world who experience this...

new migraine drug